Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
text
Tags
aduro biotech
alzheimer's disease
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
deals
detroit blog main
detroit top stories
drug prices
eli lilly
indiana blog main
indiana top stories
johnson & johnson
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
What
companies
4
×
price
4
×
drug
bio
lot
pharmaceutical
prescription
prices
roundup
accept
accepting
actor
adoption
alzheimer’s
approval
awkward
baffled
balk
big
billion
biogen’s
biopharmaceutical
bitcoin
chance
clinical
comes
convo
cryptocurrency
development
different
dollar
drug's
earlier
fail
failures
finds
gains
gave
gene
hand
Language
Current search:
price
×
companies
×
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@newsbtc.com
6 years ago
Medici Ventures’ Jonathan Johnson is “baffled” So Few Retailers Accept Bitcoin
@WIRED
8 years ago
Long before you ever have a chance to balk at prescription drug prices, the companies that make the medicine rack up billion-dollar tabs from research, ...
